# CLONAZEPAM
> **ANDA216988** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2026-05-21
## Drug
- **FDA Application Number:** ANDA216988
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLONAZEPAM
- **Generic name:** CLONAZEPAM
- **Active ingredients:** CLONAZEPAM
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2026-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216988)
---
*MORVS · CC0 1.0*